Cetilistat is a novel pancreatic lipase inhibitor for the treatment of obesity in diabetic and non-diabetic patients.
Cetilistat is a long-acting and potent specific gastrointestinal lipase inhibitor, which plays a therapeutic role by forming a covalent bond with the active serine site of gastric lipase and pancreatic lipase in the stomach and small intestine to inactivate the enzyme, the inactivated enzyme can not hydrolyze the fats in food mainly triglycerides into absorbable free fatty acids and monoacylglycerols, undigested triglycerides can not be absorbed by the body, thereby reducing calorie intake and controlling weight.
|Apperance||A White or almost white crystalline powder||Conforms|
|Loss on drying||≤1.0%||0.48%|
|Residue on Ignition||≤0.5%||0.33%|
|Appearance:||White or almost white crystalline powder|
|Package details:||1kg/foil bag;25kg/drum|
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!